Amphastar P
Price & Volume
Stats
See more52W Range | $16.64-$31.26 |
Market Cap | $934.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $730M |
Revenue Growth (YoY) | 5.4% |
Gross Profit (12 Mos) | $348.1M |
Diluted EPS | $1.72 |
News
See moreYahoo Finance • 12 days ago
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks
Yahoo Finance • 20 days ago
Amphastar anticipates $2M-$3M per quarter IMS remediation costs while maintaining mid-single digit to high single-digit 2026 sales growth
Yahoo Finance • 3 months ago
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Yahoo Finance • 3 months ago
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty
About
CEO | Dr. Yongfeng Zhang Ph.D. |
CFO | Mr. William J. Peters M.B.A. |
Address | 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,976 |